Embed Size (px)
Citation preview
EXHIBITOR & SPONSOR PROSPECTUSSUPPORTING THE PATIENT SUMMIT/Lymphedema Following Cancer Therapy: Treatment Controversies
Saturday, April 22 2017 from 8:30 AM - 2:30 PM
7TH INTERNATIONAL SYMPOSIUMAPRIL 20-22, 2017HOLIDAY INN GOLDEN GATEWAY, SAN FRANCISCO, USA
E-mail: [email protected]
SPONSORED BY THE SENTINEL NODE ONCOLOGY FOUNDATION
www.cancermetastasis.org
CANCER METASTASIS THROUGH THE LYMPHOVASCULAR SYSTEM:
BIOLOGY & TREATMENT
ABOUT THE CONGRESSSPONSORED BY THE SENTINEL NODE ONCOLOGY FOUNDATION
The Symposium is sponsored by the Sentinel Node Oncology Foundation (SNOF) whose mission is to advance the care and treatment of patients with solid cancer and to help develop new preventative strategies, diagnostics, and treatments. It is now known that the same type of cancer is different from one person to the other. After decades of research, we are poised to enter a new era of medical practice where detailed genetic and other molecular information about a patient's cancer is routinely used to deploy effective, patient-specific remedies to treat it. We are about to enter the era of precision medicine (NCI and NIH Precision Medicine Initiative®).
This CME accredited program was developed to provide a forum for discussing and presenting pre-clinical, translational and clinical re-search and thereby improve understanding, diagnosis, treatment, and quality of life of patients suffering from cancer as well as explore emerging diagnostic tools and patient-specific treatments for cancer. Lymphedema, a significant complication of cancer treatment, will be addressed and the current treatment of lymphedema will be updated. Many doctors are still very under-educated about the lymphatic system in general and, specifically, about the problem of lymphedema, which has lead to inconsistencies regarding the appropriate timing of intervention and what forms of treatment should be the standard of care. The educational objectives of the Lymphedema mini-symposium is to help participants to Identify secondary lymphedema resulting from cancer treatment and methods to overcome lym-phedema.
Target Audience: Based on the attendance history we anticipate 350-400 participants to the Cancer Metastasis Symposium, a colle-gial atmosphere with ample opportunity to network and meet with every attendee with a potential interest in your product or ser-vices. These attendees will be primarily physicians (65%) specializing in surgery, oncology, molecular imaging, plastic surgery, radia-tion oncology, thoracic medicine with the remainder a mixture of predominately PhD/scientists from both academia and biotechnol-ogy as well as a smaller groups of attendees who are in training, regulatory or from industry. The PATIENT SUMMIT/Lymphedema Following Cancer Therapy: Treatment Controversies Mini-Symposium, to be held on Saturday, will attract an additional audience of 75 - 100 therapists and nurses interested in lymphedema as well as patients and patient advocates over and above the Symposium registrants. Please review the program and the information in this prospectus and contact Joan Oefner to discuss your participation. We are happy to customize a sponsorship package based on your company?s specific needs and requirements.
Contact: Symposium Manager, Joan Oefner at [email protected]
LYMPHEMDEMA MINI-SYMPOSIUM SATURDAY, APRIL 22, 2017
07:00 - 08:30 Lymphedema Company Tabletop Exhibits Setup in Pacific Ballroom (also on Friday evening from 7:00 - 9:00 PM)
08:30-10:00 PATIENT SUMMIT/LYMPHEDEMA SESSION REGISTRATION ?HANDS-ON LE THERAPY WORKSHOPS, COFFEE BREAK, TIME FOR VISITING THE LYMPHEDEMA COMPANY EXHIBITORS & NETWORKING Pacific Ballroom
Emerald Ballroom Open to LE Session Nurses & Therapist Registrants for CME credit
08:35-10:00 Advances in Cancer Treatment for Gastrointestinal & Genitourinary Cancer based on Sentinel Lymph Node BiologySession Co-Chairs: Sukamal Saha, MD & Timothy G. Wilson, MD
10:00 - 10:30 Coffee Break - Visit the Lymphedema Company Exhibitors & Networking, Pacific Ballroom
10:35-12:20 PATIENT SUMMIT - Lymphedema Following Cancer Therapy: Treatment Controversies Co-Chairs: M ichael Bernas, MS & Saskia R.J. Thiadens, RN Emerald Ballroom
10:35 Introduction to Lymphedema, Saskia R.J. Thiadens, RN
10:45 Cancer-related lymphedema and incidence, Jane M. Armer, RN, PhD, FAAN,
11:00 Imaging techniques for the lymphatic system, Michael Bernas, MS
11:15 Genetics of cancer-related lymphedema, Betty Smoot, PT, DPTSc
11:30 Treatment and advocacy of cancer-related LE, Saskia R.J. Thiadens, RN
11:45 Surgical treatments for lymphedema, Jay Granzow, MD, MPH, FACS
12:05 Q&A Panel Discussion
12:20-13:30 Industry Sponsored Lymphedema Lunch Session, Pacific Ballroom, Speakers and Sponsors TBD, Non-CME
13:35 - 15:05 Radiotherapy of Cancer, Session Co-Chairs: Roy Abendroth, MD & Baldassare Stea, MD
14:30 Lymphedema Company Exhibitors Tear Down Tabletops from Pacific Ballroom
INDUSTRY SUPPORT OPPORTUNITIES
EXHIBIT SPACE: (SPACE IS LIM ITED TO 7 TABLETOPS IN THE PACIFIC BALLROOM FOR LYMPHEDEMA COMPANIES ON SATURDAY ONLY, AND 18 TABLETOPS INSIDE THE GOLD RUSH BALLROOM FOR THE 3 DAY SYMPOSIUM)
- LYMPHEDEMA SESSION TABLETOP IN PACIFIC BALLROOM, SATURDAY ONLY: $850- LYMPHEDEMA SESSION TABLETOP FOR NON-PROFIT, SATURDAY ONLY: $250
EXHIBITS INCLUDE ONE 6? X 30? DRAPED TABLE WITH TWO CHAIRS.
Setup of Saturday Only exhibits is on Friday evening, April 21, 2017 from 8 - 10 PM or Saturday morning, 6:30 - 7:30 AM.
LYMPHEDEMA COMPANY EDUCATIONAL SESSION SPONSORSHIP:Saskia R.J. Thiadens, RN and Michael J. Bernas, MSN, Co-Chairs of the Patient Summit-Lymphedema Following Cancer Therapy: Treatment Controversies Mini-Symposium, invite Lymphedema Companies to support this important session. Registration prices have been deeply discounted to encourage patients, patient advocates as well as nurses and therapists treating patients with Lymphedema to participate.
We are seeking company support for the following items:
Lunch Session with 1-2 speakers for Saturday, following the session: Cost of Sponsorship: $3,500 plus speaker costs. Lunches, meeting room and AV equipment are included in the sponsorship.
ADDITIONAL SPONSORSHIPS SINGLE SUPPORT OPPORTUNITIES for Lymphedema Companies in support of the PATIENT SUMMIT - Lymphedema Following Cancer Therapy: Treatment Controversies, Saturday, April 22, 2017
Co-Chairs: Saskia R.J. Thiadens, RN & Michael Bernas, MS
1. Non-CME Educational Lunch Session, includes food, AV, meeting room up to100 participants: $3,500. Supporter is responsible for speaker costs . This lunch session is open to all those registered for the Patient Summit/LE Session. The total presentation time of 60 minutes may be shared between 2-3 Lymphedema companies, thereby splitting the cost.
2. Continuous Coffee Break for Registration and Networking from 8:30 - 10:00 AM on Saturday for Patients, Patient Advocates, Nurses and Therapists not attending CE sessions: $2,500
3. Lymphedema Therapy Hands-On Workshops: $2,0004. Acknowledgement of support of Patients and Patient Advocates registration fee reduction: $1,0005. Acknowledgement of support for therapists and nurses registration fee reduction: $1,5006. Acknowledgment as sponsor of the 9:45 - 10:15 AM Coffee Break for all attendees
of the Cancer Metastasis Symposium & Patient Summit/LE Session: $2,500 - LYMPHEDEMA SESSION TABLETOP IN PACIFIC BALLROOM, SATURDAY ONLY: $850- LYMPHEDEMA SESSION TABLETOP FOR NON-PROFIT, SATURDAY ONLY: $250
Pacific Ballroom is also the location of Symposium E-Posters.
SUPPORT BENEFITSAlong with other benefits of associating with this premier academic conference that follows the journey of cancer metastasis from detection at the molecular level to genomic identification to precision treatment & survival, all supporting companies will receive a dedicated page on www.cancermetastasis.org, to include information such as:
- Company profile, website link, logo- Pictures- Documents, open access manuscripts- Videos- Presentations- Brochures- Other relevant information of interest to participants of Cancer Metastasis 2017- Inclusion in the Symposium Social Media (Facebook, LinkedIn and Twitter).
Other benefits of support:
- Logo to be included on signage near the Exhibit Hall Entrance and on specific items that are being supported;- Acknowledgement in the Symposium Final Program on USB & the Schedule at a Glance - Use of Symposium logo for supporter?s own promotional purposes (must be approved by the Organizing Committee); - Pre & post registration lists identifying attendees names, affiliations & addresses (not applicable for Tote Bag Insert Item).- Assistance with registration at sponsored sessions. - Continued presence on www.cancermetastasis.org Virtual Meeting.
Please contact Joan Oefner at [email protected] to discuss your ideas for a customized support package that would best fit the needs of your company. The Cancer Metastasis through the Lymphovascular System: Biology & Treatment, 7th International Symposium is sponsored by the Sentinel Node Oncology Foundation which is incorporated as a 501 (c) 3 non-profit organization. Tax ID is 20-0173930.
